Table 3. Correlation between high postNLR and clinicopathological indicators.
| Clinicopathological indicators | studies | patients | OR (95CI%) | I2 | P |
|---|---|---|---|---|---|
| Age≥60 years VS Age<60 years | 5 | 840 | 1.04 (0.65–1.67) | 59% | 0.87 |
| Male VS female | 10 | 1672 | 0.78 (0.56–1.10) | 59% | 0.16 |
| CEA normal VS elevated | 4 | 576 | 0.67 (0.41–1.09) | 28% | 0.11 |
| AJCC (7th) III+IV VS I+II | 2 | 281 | 7.67 (0.08–709.58) | 94% | 0.38 |
| AJCC (7th) T III+IV VS T I+II | 3 | 601 | 0.29 (0.06–1.31) | 91% | 0.11 |
NLR, neutrophil-lymphocyte ratio; OR, odds ratio; CEA, carcinoembryonic antigen; AJCC (7th), 7th edition of the American Joint Committee on Cancer staging system.